tirzepatide at room temperature Storage Guide: Do's, Don'ts and Cooling Tips Tirzepatide Injection Storage: Cold or

Clinical studies have shown that tirzepatide: Significantly reduces hemoglobin A1C levels compared to placebo Promotes weight loss in a dose-dependent manner May have potential benefits for non-alcoholic fatty liver disease (NAFLD) patients Tirzepatide is typically administered as follows: Once-weekly subcutaneous injection Available in various strengths (e.g., 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg) Dose is usually titrated over time to reach the target dose Common side effects may include: Nausea Diarrhea Decreased appetite Vomiting Constipation Abdominal pain Tirzepatide should be used with caution in patients with: History of pancreatitis Severe gastrointestinal disease Diabetic retinopathy Pregnancy: Tirzepatide should not be used during pregnancy unless the potential benefit justifies the potential risk to the fetus

Safety and Tolerability Another reason why Thymosin Alpha-1 has been seeing a surge in popularity is because it has been shown to have great tolerability and adverse side effects are uncommon

In mid and south Essex, access to tirzepatide will initially be through specialist weight management services only

Tier 2 covers preferred brand-name medications